Home › Compare › LRCFF vs JNJ

LRCFF vs JNJ: Dividend Comparison 2026

LRCFF yields 13333.33% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LRCFF wins by $944051876715324800.00M in total portfolio value
10 years
LRCFF
LRCFF
● Live price
13333.33%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$944051876715324800.00M
Annual income
$930,326,183,604,330,300,000,000.00
Full LRCFF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — LRCFF vs JNJ

📍 LRCFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLRCFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LRCFF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LRCFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LRCFF
Annual income on $10K today (after 15% tax)
$1,133,333.33/yr
After 10yr DRIP, annual income (after tax)
$790,777,256,063,680,700,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, LRCFF beats the other by $790,777,256,063,680,700,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LRCFF + JNJ for your $10,000?

LRCFF: 50%JNJ: 50%
100% JNJ50/50100% LRCFF
Portfolio after 10yr
$472025938357662400.00M
Annual income
$465,163,091,802,165,140,000,000.00/yr
Blended yield
98.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LRCFF
No analyst data
Altman Z
-11.6
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LRCFF buys
0
JNJ buys
0
No recent congressional trades found for LRCFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLRCFFJNJ
Forward yield13333.33% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$944051876715324800.00M ✓$20.0K
Annual income after 10y$930,326,183,604,330,300,000,000.00 ✓$827.78
Total dividends collected$943142383073684224.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LRCFF vs JNJ ($10,000, DRIP)

YearLRCFF PortfolioLRCFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,344,033$1,333,333.33$10,676$355.77+$1.33M → LRCFF
2$168,918,905$167,480,789.20$11,407$389.39+$168.91M → LRCFF
3$19,852,785,021$19,672,041,793.12$12,198$426.53+$19852.77M → LRCFF
4$2,182,013,981,744$2,160,771,501,770.83$13,056$467.62+$2182013.97M → LRCFF
5$224,287,824,199,531$221,953,069,239,064.90$13,987$513.12+$224287824.19M → LRCFF
6$21,561,870,489,323,890$21,321,882,517,430,390.00$14,998$563.56+$21561870489.31M → LRCFF
7$1,938,749,165,623,537,400$1,915,677,964,199,961,300.00$16,098$619.52+$1938749165623.52M → LRCFF
8$163,055,200,603,353,700,000$160,980,738,996,136,500,000.00$17,295$681.69+$163055200603353.69M → LRCFF
9$12,827,750,571,022,997,000,000$12,653,281,506,377,408,000,000.00$18,599$750.82+$12827750571022998.00M → LRCFF
10$944,051,876,715,324,800,000,000$930,326,183,604,330,300,000,000.00$20,022$827.78+$944051876715324800.00M → LRCFF

LRCFF vs JNJ: Complete Analysis 2026

LRCFF — Stock

Lovitt Resources Inc., through its subsidiary, Lovitt Mining Company, Inc., focuses on the acquisition, exploration, and development of gold and silver properties in the United States and Canada. It holds interests in the Lovitt gold mine; and other mining assets consisting of approximately 250 acres of real estate located in Wenatchee, Washington. The company was formerly known as Lovitt Nutriceutical Corporation and changed its name to Lovitt Resources Inc. in September 2008. Lovitt Resources Inc. was incorporated in 1980 and is based in Surrey, Canada.

Full LRCFF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this LRCFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LRCFF vs SCHDLRCFF vs JEPILRCFF vs OLRCFF vs KOLRCFF vs MAINLRCFF vs ABBVLRCFF vs MRKLRCFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.